Enhancing clinical research in India with publicly accessible histopathological image datasets for cancer and kidney disease ...

People with lupus-related skin problems are more likely to develop heart disease associated with hardening of the a ...

Houston Methodist researchers have identified a key protein as a potential therapeutic target for stopping the body's immune ...

Hyderabad: IIIT Hyderabad, in collaboration with Nizam's Institute of Medical Sciences (NIMS), has released digitised ...

PhaseV, a leader in software and machine learning (ML) for advanced clinical development optimization, today announced it has ...

On Tuesday, the U.S. Food and Drug Administration (FDA) placed a clinical hold on Atara Biotherapeutics, Inc.’s (NASDAQ:ATRA) ...

Lupus is a chronic disease that can cause inflammation and pain in any part of the body. It’s an autoimmune disease, which ...

However, for the vast majority of lupus flares the initial treatment has to be systemic glucocorticoids. For most manifestations, prednisone at 0.25–0.5 mg/kg body weight (or equivalent ...

ImmuPharma plc (LON:IMM – Get Free Report) rose 27.6% on Saturday . The company traded as high as GBX 3.60 ($0.04) and last ...

Cutaneous lupus erythematosus (CLE) is associated with an increased risk for atherosclerotic cardiovascular disease ...

Atara Biotherapeutics said the U.S. Food and Drug Administration placed a clinical hold on its active investigational new drug applications. The biotechnology company said the FDA put a hold on its ...